Jazz Pharmaceuticals plc 4

Neena M. Patil (EVP & Chief Legal Officer) sold 1,200 Ordinary Shares of Jazz Pharmaceuticals plc at about $240.94 per share under a Rule 10b5-1 plan.

On September 10, 2026, Neena M. Patil, EVP & Chief Legal Officer of Jazz Pharmaceuticals plc, sold 1,200 Ordinary Shares at an average price of $240.94 per share under a pre-arranged Rule 10b5-1 trading plan, for total proceeds of approximately $289,128, reducing but still leaving her with a sizable direct ownership position of 47,671 shares in the company. The transaction was executed automatically pursuant to the plan and is characterized as a routine, non-discretionary insider sale rather than an opportunistic trade.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001783908-26-000022

Alert Tier

6